Li Q, Qiu Q, Zhang L, Zhang X, Wang Y, Geng Z, Ge S, Zuo L, Song X, Li J, Hu J
Clinical Laboratory, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Bengbu Medical College, Bengbu 233030, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):633-640. doi: 10.12122/j.issn.1673-4254.2022.05.02.
To investigate the expression of aldehyde dehydrogenase 3B1 (ALDH3B1) in gastric cancer and explore its correlation with the pathological parameters and long-term prognosis of the patients.
We analyzed the clinical data of 101 patients who underwent radical gastrectomy for gastric cancer in our hospital between January, 2013 and November, 2016, and examined the expression of ALDH3B1 in paraffin-embedded samples of gastric cancer tissues and adjacent tissues from these cases by immunohistochemical staining. We evaluated the correlation between ALDH3B1 expressions and histopathological parameters and assessed the predictive value of ALDH3B1 expression for long-term survival of the patients. We also examined the effect of lentivirus-mediated interference and overexpression of ALDH3B1 on the malignant behaviors of MGC-803 gastric cancer cells.
The expressions of ALDH3B1 and Ki67 were significantly higher in gastric cancer tissues than in adjacent tissues ( < 0.05). In gastric cancer patients, ALDH3B1 expression was positively correlated with peripheral blood CEA and CA19-9 levels ( < 0.01). The proportion of patients with CEA ≥5 μg/L, CA19-9 ≥37 kU/L, T stage of 3- 4, and N stage of 2-3 was significantly greater in high ALDH3B1 expression group than in low expression group. Kaplan-Meier survival analysis showed that the 5-year survival rate was significantly lower in gastric cancer patients with high ALDH3B1 expressions ( < 0.01). Univariate and Cox multiple regression analyses identified a high expression of ALDH3B1 ( < 0.05, HR= 0.231, 95% : 0.064-0.826), CEA≥5 μg/L ( < 0.01, HR=4.478, 95% : 1.530-13.110), CA19-9≥37 kU/L ( < 0.01, HR=3.877, 95% : 1.625-9.247), T stage of 3-4 ( < 0.01, HR=4.953, 95% : 1.768-13.880), and N stage of 2-3 ( < 0.05, HR=2.152, 95% : 1.152-4.022) as independent risk factors affecting 5-year survival after radical gastrectomy. The relative ALDH3B1 expression level, at the cut-off point of 4.66, showed a sensitivity of 76.47% and a specificity of 76% for predicting 5-year postoperative death ( < 0.01). In the cell experiment, overexpression of ALDH3B1 obviously promoted the proliferation, migration and invasion of MGC-803 cells.
As an independent risk factor affecting 5-year survival after radical gastrectomy, ALDH3B1 is highly expressed in gastric cancer and correlated with pathological parameters of the tumor, and a high ALDH3B1 expression may promote proliferation, invasion and metastasis of gastric cancer cells.
探讨醛脱氢酶3B1(ALDH3B1)在胃癌中的表达情况,并探究其与患者病理参数及长期预后的相关性。
分析我院2013年1月至2016年11月期间101例行胃癌根治术患者的临床资料,采用免疫组织化学染色法检测这些病例胃癌组织及癌旁组织石蜡包埋样本中ALDH3B1的表达。评估ALDH3B1表达与组织病理学参数之间的相关性,并评估ALDH3B1表达对患者长期生存的预测价值。同时检测慢病毒介导的ALDH3B1干扰和过表达对MGC-803胃癌细胞恶性行为的影响。
胃癌组织中ALDH3B1和Ki67的表达显著高于癌旁组织(P<0.05)。在胃癌患者中,ALDH3B1表达与外周血CEA和CA19-9水平呈正相关(P<0.01)。ALDH3B1高表达组中CEA≥5μg/L、CA19-9≥37kU/L、T分期为3-4期、N分期为2-3期的患者比例显著高于低表达组。Kaplan-Meier生存分析显示,ALDH3B1高表达的胃癌患者5年生存率显著较低(P<0.01)。单因素和Cox多因素回归分析确定ALDH3B1高表达(P<0.05,HR=0.231,95%CI:0.064-0.826)、CEA≥5μg/L(P<0.01,HR=4.478,95%CI:1.530-13.110)、CA19-9≥37kU/L(P<0.01,HR=3.877,95%CI:1.625-9.247)、T分期为3-4期(P<0.01,HR=4.953,95%CI:1.768-13.880)和N分期为2-3期(P<0.05,HR=2.152,95%CI:1.152-4.022)是影响胃癌根治术后5年生存的独立危险因素。相对ALDH3B1表达水平在截断点为4.66时,预测术后5年死亡的敏感度为76.47%,特异度为76%(P<0.01)。在细胞实验中,ALDH3B1过表达明显促进了MGC-803细胞的增殖、迁移和侵袭。
作为影响胃癌根治术后5年生存的独立危险因素,ALDH3B1在胃癌中高表达,且与肿瘤病理参数相关,高ALDH3B1表达可能促进胃癌细胞的增殖、侵袭和转移。